1-8 of 8
Hyang-Min Byun
Close
Sort by
Journal Articles

A Phase I Biological Study of Azacitidine (Vidaza) to Determine the Optimal Biological Dose and Route of Administration.

Ilan Bernstein, MD, Hyang-Min Byun, PhD, Ann Mohrbacher, MD, Dan Douer, MD, Gerry Gorospe, III, RN, BSN, MSN, Allen S. Yang, MD, PhD, Casey L O'Connell, MD
Journal: Blood
Blood (2009) 114 (22): 1753.
https://doi.org/10.1182/blood.V114.22.1753.1753
Published: 2009
Journal Articles

Genome-Wide DNA Methylation Analysis of Patients with Myelodysplastic Syndrome After Azacitidine Treatment.

Hyang-Min Byun, PhD, Timothy Triche, Jr., M.S., Hyeoung-Joon Kim, MD, PhD, Hee Nam Kim, PhD, Yeo-Kyeoung Kim, MD, Il-Kwon Lee, Ph.D., Jae-Sook Ahn, MD, Je-Jung Lee, MD, Deok-Hwan Yang, MD, Hoon Kook, MD, Tai Ju Hwang, MD, Peter W. Laird, PhD, Daniel Weisenberger, Ph.D., Allen S. Yang, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 600.
https://doi.org/10.1182/blood.V114.22.600.600
Published: 2009
Journal Articles

Molecular Predictive Markers in Dose Escalation Treatment for Suboptimal Responders to Standard Dose Imatinib in CML

Youngil Koh, Dae-Young Kim, Hyuk-Chan Kwon, Min Kyoung Kim, Byung-Soo Kim, Yu-Kyung Kim, Inho Kim, Jae Seog Kim, Jin Seog Kim, Chul Soo Kim, Hyeoung-Joon Kim, Jae-Yong Kwak, Na-Ri Lee, Yoo-Hong Min, Chong Won Park, Sang Kyun Sohn, Ho-Jin Shin, Suk Joong Oh, Sung-Soo Yoon, Jung-Hee Lee, Dae Young Zang, Jooseop Chung, Jun-Won Cheong, Chul W. Jung, Deog-Yeon Jo, Yeun-Jun Chung, Seung-Hyun Jung, Hai-Dong Xu, Hyang-Min Byun, Allen S. Yang, MD, PhD, Seonyang Park
Journal: Blood
Blood (2008) 112 (11): 3221.
https://doi.org/10.1182/blood.V112.11.3221.3221
Published: 2008
Journal Articles

Phasee I Biological Study of IV and SQ Azacitidine (Vidaza®) to Determine the Optimal Biological Dose in Hematologic Malignancies

Allen S. Yang, MD, PhD, Ann Mohrbacher, MD, Dan Douer, MD, Gerry Gorospe, III, RN, BSN, MSN, Hyang-Min Byun
Journal: Blood
Blood (2008) 112 (11): 4493.
https://doi.org/10.1182/blood.V112.11.4493.4493
Published: 2008
Journal Articles

DNA Methylation Analysis of 807 Genes in Chronic Myeloid Leukemia and Acute Promyelocytic Leukemia.

Hyang-Min Byun, Ph.D., Shahrooz Eshaghian, M.D., Jia Yi Jiang, M.D., Si Ho Choi, M.S., John Soussa, Laleh Ramezani, B.S.C., Dan Douer, M.D., Allen S. Yang, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2122.
https://doi.org/10.1182/blood.V110.11.2122.2122
Published: 2007
Journal Articles

Changes in DNA Methylation of Repetitive Elements during the Progression of Chronic Myelogenous Leukemia.

Si Ho Choi, MS, Hyang-Min Byun, Ph.D, Jia Yi Jiang, MD, Guillermo Garcia-Manero, MD, Allen S. Yang, MD, Ph.D
Journal: Blood
Blood (2006) 108 (11): 4302.
https://doi.org/10.1182/blood.V108.11.4302.4302
Published: 2006
Journal Articles

Hydroxyurea with Azacitidine or Decitabine in Combination Is Antagonistic on DNA Methylation Inhibition.

Si Ho Choi, MS, Hyang-Min Byun, Ph.D, Jennifer Kwan, BS, Allen S. Yang, MD, Ph.D
Journal: Blood
Blood (2006) 108 (11): 4303.
https://doi.org/10.1182/blood.V108.11.4303.4303
Published: 2006
Journal Articles

Methylation Profiling of Three Homogenous Cancers: Chronic Myelogenous Leukemia (CML), Acute Promyelocytic Leukemia (APL) and Gastrointestinal Stromal Tumors (GIST).

Hyang-Min Byun, PhD, Shahrooz Eshaghian, MD, Jia Yi Jiang, MD, Si Ho Choi, MS, Laleh Ramezani, BSC, Dan Douer, MD, Guillermo Garcia-Manero, MD, Jean-Pierre Issa, MD, Dan Yang, MD, Ph.D, Jonathen Trent, MD, Ph.D, Allen S. Yang, MD, Ph.D
Journal: Blood
Blood (2006) 108 (11): 736.
https://doi.org/10.1182/blood.V108.11.736.736
Published: 2006